AIMIA shares are trading lower after the company announced a definitive agreement to sell its specialty chemicals business, Bozzetto, which is part of its strategic restructuring plan.

Inotiv shares are trading lower after the company reported a 5.3% increase in operating losses for Q1 FY 2026, signaling financial struggles despite a slight revenue rise.

Cleveland-Cliffs shares are trading lower after the company reported a GAAP net loss of $1.4 billion for 2025, with challenges stemming from weak automotive production and the adverse impact of an expiring slab contract.

PLBY shares are trading higher after Playboy entered into a $122 million deal with United Trademark Group to boost growth in China, while planning to use $50 million to reduce debt.

Waters Corporation shares are trading lower after reporting fourth-quarter financial results that missed expectations. The company's GAAP earnings per share decreased to $3.77 from $3.88 the previous year, despite a 7% increase in sales. Increased costs, including selling and administrative expenses, impacted operating income, contributing to the negative stock price movement.

Motorcar Parts of America shares are trading lower after the company reported a decrease in sales and net income for its fiscal 2026 third quarter due to reduced ordering by a major customer.

Humacyte shares are trading higher after the company announced new funding from the U.S. Department of Defense to support the procurement of its bioengineered blood vessels for treating traumatic vascular injuries.

FG Nexus shares are trading lower after the company announced a 1-for-5 reverse stock split to enhance trading liquidity and broaden institutional appeal.

Momentus shares are trading higher after the company announced a strategic partnership with NASA to advance in-orbit servicing and assembly capabilities, marking a significant milestone in space technology innovation.

Kyndryl shares are trading lower after the company reported a decreased pre-tax income of $91 million, down significantly from $258 million in the prior year, alongside stagnant revenue growth in constant currency.

Dynatrace shares are trading higher after the company reported strong third-quarter financial results, surpassing guidance, and announced a new $1 billion share repurchase program.

Outdoor Holding Company shares are trading higher after the company reported a 7% increase in net revenues and achieved its second consecutive quarter of net profitability.

BILL shares are trading higher after the company reported a significant beat on Q2 revenue and profitability. Core revenue increased by 17% year-over-year, driven by a rise in transaction fees. The company also announced a guidance for continued growth in the fiscal third quarter and full fiscal year 2026.

Healthcare Triangle, Inc. shares are trading lower after the company announced a 1-for-60 reverse stock split as part of its strategy to regain Nasdaq compliance.

Pulse Biosciences shares are trading higher after the company announced promising results from a feasibility study of its nPulse Cardiac Catheter, showcasing successful atrial fibrillation treatments with rapid procedure times and minimal adverse effects.

Anebulo Pharmaceuticals shares are trading lower after the company announced its board's approval for the voluntary delisting of its common stock from Nasdaq and the deregistration with the SEC, citing the costs and burdens of remaining a registered public company.

SunOpta shares are trading higher after Refresco agreed to acquire the company for $6.50 per share in cash, significantly broadening its plant-based beverage category presence.

Smartkem shares are trading higher after the company announced a debt conversion agreement, reducing accounts payable by approximately $2.0 million.

Newell Brands shares are trading lower after the company reported a year-over-year decline in net sales and a significant operating loss, impacted by tariff costs and inflation.

Clearmind Medicine shares are trading higher after the company announced a development agreement with Polyrizon to enhance the formulation of its proprietary non-hallucinogenic neuroplastogen MEAI for intranasal delivery.